Share Us: Email Icon Facebook icon Twitter Icon GooglePlus Icon Facebook Like icon   Subscribe | Contact

User Top Menu

Latest News

4 September 2015

2015 JAD Editorial Board Meeting

On July 20, 2015, JAD Editor-in-Chief George Perry, PhD, presented statistics and policies related to the Journal of Alzheimer’s Disease, including its new website developments. The presentation is published here for all JAD editors and readers to view. Over 90 Editorial Board members attended the meeting.

24 August 2015

Waterford research on Alzheimer’s disease suggests that measuring macular pigment offers potential as a biomarker of cognitive health

Ongoing European Research Council-funded research at Waterford Institute of Technology’s (WIT) Macular Pigment Research Group (MPRG) is investigating the potential link between cognitive function and levels of a vital eye pigment linked to diet. The study suggests that measuring macular pigment offers potential as a biomarker of cognitive health.

28 July 2015

Coffee Consumption Habits Impact the Risk of Mild Cognitive Impairment: The Italian Longitudinal Study on Aging

A new study estimates the association between change or constant habits in coffee consumption and the incidence of mild cognitive impairment, evaluating 1,445 individuals recruited from 5,632 subjects, aged 65-84 year old, from the Italian Longitudinal Study on Aging, a population-based sample from eight Italian municipalities with a 3.5-year median follow-up.

14 July 2015

Affordable, Non-Invasive Test May Detect Who is Most at Risk for Alzheimer's

Photo caption:  Dr. John Hart Jr. (left) and Dr. Hsueh-Sheng Chiang (right), with researchers Drs. Jeremy Strain and Neena Rao, led the study on a new non-invasive test for Alzheimer's disease.

Individuals with amnestic mild cognitive impairment (aMCI) are at twice the risk of others in their age group of progressing to Alzheimer’s disease. Although no conclusive test exists to predict who will develop Alzheimer’s, new research from the Center for BrainHealth at The University of Texas at Dallas is attempting to identify a potential biomarker that could offer a more complete picture of who is most at risk.

26 June 2015

Hartmuth Kolb, PhD, Wins 2015 Alzheimer Award

Hartmuth Kolb

The Journal of Alzheimer’s Disease is proud to announce that Hartmuth Kolb, PhD, Head of Neuroscience Biomarkers, Johnson & Johnson, San Diego, CA, has been chosen as the recipient of the 2015 Alzheimer Award presented by the Journal of Alzheimer’s Disease in recognition of his outstanding work on the importance and imaging of neurofibrillary tangles and Alzheimer’s disease.


Subscribe to Latest News